T1	Participants 250 282	femoropopliteal arterial disease
T2	Participants 491 544	patients with symptomatic peripheral arterial disease
T3	Participants 735 890	266 patients with stenotic or occluded superficial femoral or popliteal arteries were prospectively randomized to treatment with the IntraCoil stent or PTA
